DCB Unveiled: Bridging Science and Application – Ep 5: What is the Difference Between the Two Drugs in the Context of DCB?
Join host Dr Rasha Al-Lamee in this exciting new episode, as she is joined by Prof Michael Joner and Prof Bruno Scheller to delve into the distinctive properties of two commonly utilised drugs in the field of DCB.
Increase your understanding of these products by tuning in to this enlightening 15-minute discussion, where you will gain insights on key features and the safety profile, provided with the latest updates from the FDA.
Read MoreRead Less
This podcast series is supported by
Read MoreRead Less
Also listen on
In this episode, Dr Rasha Al-Lamee and Prof Azfar Zaman lead the discussion on managing small vessel disease and the evolving role of DCB in its treatment, including safety considerations when using DCB in small vessels.
Read More
All Episodes
Introducing our new podcast series, DCB Unveiled: Bridging Science and Application, hosted by Dr Rasha Al-Lamee.
Read More
In this final episode, Dr Rasha Al-Lamee and Dr Darren Mylotte provide a comprehensive summary of where we are currently with DCB and then look forwards by exploring the evolving landscape of DCB and their potential applications in the future.
Read More
Host, Dr Rasha Al-Lamee, is joined by Dr Luca Testa in this episode to compare the use of scaffolds versus no scaffolds, highlighting key differences.
Read More
In this insightful episode, the focus is on the crucial aspects of lesion preparation for DCB.
Read More
In this episode, Dr Rasha Al-Lamee and Prof Azfar Zaman lead the discussion on managing small vessel disease and the evolving role of DCB in its treatment, including safety considerations when using DCB in small vessels.
Read More